Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.

Fuji S, Makiyama J, Takano K, Choi I, Suzuki T, Suminaka C, Kuroishi M, Iwasaki Y, Kasahara H, Tada Y, Shingai Y, Yuda S, Yokota T, Ishikawa J

Open source

DOI: 10.1002/jha2.70046
Published: 2025 Aug
Container: EJHaem
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jha2.70046,
  title = {Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.},
  author = {Fuji S and Makiyama J and Takano K and Choi I and Suzuki T and Suminaka C and Kuroishi M and Iwasaki Y and Kasahara H and Tada Y and Shingai Y and Yuda S and Yokota T and Ishikawa J},
  year = {2025},
  journal = {EJHaem},
  doi = {10.1002/jha2.70046},
  url = {https://doi.org/10.1002/jha2.70046}
}

RIS

TY  - JOUR
TI  - Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.
AU  - Fuji S
AU  - Makiyama J
AU  - Takano K
AU  - Choi I
AU  - Suzuki T
AU  - Suminaka C
AU  - Kuroishi M
AU  - Iwasaki Y
AU  - Kasahara H
AU  - Tada Y
AU  - Shingai Y
AU  - Yuda S
AU  - Yokota T
AU  - Ishikawa J
PY  - 2025
JO  - EJHaem
DO  - 10.1002/jha2.70046
UR  - https://doi.org/10.1002/jha2.70046
ER  -

APA

S, F., J, M., K, T., I, C., T, S., C, S., M, K., Y, I., H, K., Y, T., Y, S., S, Y., T, Y., & J, I. (2025). Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.. EJHaem. https://doi.org/10.1002/jha2.70046

Source records

pubmed · retrieved 2026-09-27T01:00:17.517Z